<p>A) HIV-1 replication kinetics of the hyper-, lab-, and hypo-Vif variants in CD4+ T lymphocytes from a representative healthy donor encoding unstable A3H haplotype I/I (donor 2). Data from additional experiments using independent donors are shown in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1004761#pgen.1004761.s003" target="_blank">Figure S3</a>. Y-axis values represent p24 levels measured by ELISA. B) HIV-1 replication kinetics of the hyper-, lab-, and hypo-Vif variants in CD4+ T lymphocytes from a representative healthy donor encoding one allele of stable A3H haplotype II (and one allele of unstable A3H haplotype I; donor 4). Data from additional experiments using independent donors are shown in <a href...
UNLABELLED: Members of the apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3 (APOBEC...
OBJECTIVES: In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases su...
<p>(A) Replication of HIV<sub>JR-CSF</sub>, HIV<sub>JR-CSF</sub>Δ<i>vif</i>, and HIV<sub>JR-CSF</sub...
SummarySeveral human APOBEC3 deaminases can inhibit HIV-1 replication in vitro. HIV-1 Vif counteract...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
The rapid evolution of Human Immunodeficiency Virus (HIV-1) allows studies of ongoing host–pathogen ...
Supplemental Experimental Procedures hr later. Viral stocks were normalized for reverse transcriptas...
Human APOBEC3 enzymes are cellular DNA cytidine deaminases that inhibit and/or mutate a variety of r...
The evolutionary success of primate lentiviruses reflects their high capacity to mutate and adapt to...
<p>G-to-A mutation rates were estimated for (A) HIV-1 NL4-3 WT versus ΔVif infected LPMCs at 4 dpi; ...
BACKGROUND: Naturally occurring Vif variants that are unable to inhibit the host restriction factor ...
SummarySeveral human APOBEC3 deaminases can inhibit HIV-1 replication in vitro. HIV-1 Vif counteract...
International audienceThe cytidine deaminase APOBEC3G (A3G) enzyme exerts an intrinsic anti-human im...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
Objectives: In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases su...
UNLABELLED: Members of the apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3 (APOBEC...
OBJECTIVES: In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases su...
<p>(A) Replication of HIV<sub>JR-CSF</sub>, HIV<sub>JR-CSF</sub>Δ<i>vif</i>, and HIV<sub>JR-CSF</sub...
SummarySeveral human APOBEC3 deaminases can inhibit HIV-1 replication in vitro. HIV-1 Vif counteract...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
The rapid evolution of Human Immunodeficiency Virus (HIV-1) allows studies of ongoing host–pathogen ...
Supplemental Experimental Procedures hr later. Viral stocks were normalized for reverse transcriptas...
Human APOBEC3 enzymes are cellular DNA cytidine deaminases that inhibit and/or mutate a variety of r...
The evolutionary success of primate lentiviruses reflects their high capacity to mutate and adapt to...
<p>G-to-A mutation rates were estimated for (A) HIV-1 NL4-3 WT versus ΔVif infected LPMCs at 4 dpi; ...
BACKGROUND: Naturally occurring Vif variants that are unable to inhibit the host restriction factor ...
SummarySeveral human APOBEC3 deaminases can inhibit HIV-1 replication in vitro. HIV-1 Vif counteract...
International audienceThe cytidine deaminase APOBEC3G (A3G) enzyme exerts an intrinsic anti-human im...
AbstractAPOBEC3G (A3G) and APOBEC3F (A3F) reduce Vif-negative HIV-1 provirus formation and cause dis...
Objectives: In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases su...
UNLABELLED: Members of the apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3 (APOBEC...
OBJECTIVES: In the absence of HIV-1 virion infectivity factor (Vif), cellular cytosine deaminases su...
<p>(A) Replication of HIV<sub>JR-CSF</sub>, HIV<sub>JR-CSF</sub>Δ<i>vif</i>, and HIV<sub>JR-CSF</sub...